Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

OLVI Aktie

>OLVI Performance
1 Woche: 0%
1 Monat: -2,2%
3 Monate: +0,7%
6 Monate: +16,8%
1 Jahr: +7,3%
laufendes Jahr: +18,4%
>OLVI Aktie
Name:  OLVI OY A EO 1
Land:  Finnland
Sektor:  Konsumgueter / Gastronomie
ISIN/ Wkn:  FI0009900401 / 898037
Symbol/ Ticker:  OVI (Frankfurt)
Kürzel:  FRA:OVI, ETR:OVI, OVI:GR
Index:  -
Webseite:  https://www.olvi.fi/
Marktkapitalisierung:  691.41 Mio. EUR
Umsatz:  659.33 Mio. EUR
EBITDA:  106.73 Mio. EUR
Gewinn je Aktie:  3.01 EUR
Schulden:  23.91 Mio. EUR
Liquide Mittel:  34.67 Mio. EUR
Umsatz-/ Gewinnwachstum:  1.9% / 8.4%
KGV/ KGV lG:  11.21 / -
KUV/ KBV/ PEG:  1.06 / 2.07 / -
Gewinnm./ Eigenkapitalr.:  9.47% / 20.63%
Dividende je Aktie:  1.25 EUR
Dividendenrendite/ -schätzung:  3.7% / 3.85%
Div. Historie:  17.04.25 - 0.65€
26.08.24 - 0.6€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  OLVI
Letzte Datenerhebung:  05.07.25
>OLVI Eigentümer
Aktien: 16.97 Mio. St.
f.h. Aktien: 15.05 Mio. St.
Insider Eigner: 8.81%
Instit. Eigner: 26.51%
Leerverk. Aktien: -
>OLVI Peer Group

 
04.07.25 - 08:18
Olvi plc: Notification of Managers′ Transactions (Akkel) (Cision)
 
Olvi plc   Stock exchange release 4 July 2025 at 9:15 a.m.   Olvi plc: Notification of Managers' Transactions (Akkel)   Person subject to the notification requirement Name: Akkel Peep Position: Other senior manager Issuer Name: Olvi plc LEI: 7437003NX7WWVRT6AJ55 Initial notification Reference number: 115367/4/4 Transaction details Transaction date: 1.7.2025 Venue: Outside a trading venue Nature of transaction: Receipt of a share-based incentive Instrument: Share ISIN: FI0009900401 Volume: 240 Unit price: 0 EUR Aggregated transactions Volume: 240 Average...
04.07.25 - 07:12
Olvi plc: Notification of Managers′ Transactions (Hortling) (Cision)
 
Olvi plc   Stock exchange release 4 July 2025 at 8:10 a.m.   Olvi plc: Notification of Managers' Transactions (Hortling)   Person subject to the notification requirement Name: Hortling Pia Position: Other senior manager Issuer Name: Olvi plc LEI: 7437003NX7WWVRT6AJ55 Initial notification Reference number: 115348/7/4 Transaction details Transaction date: 1.7.2025 Venue: Outside a trading venue Nature of transaction: Receipt of a share-based incentive Instrument: Share ISIN: FI0009900401 Volume: 480 Unit price: 0 EUR Aggregated transactions Volume: 480...
04.07.25 - 07:06
Olvi plc: Notification of Managers′ Transactions (Rissanen) (Cision)
 
Olvi plc   Stock exchange release 4 July 2025 at 8:05 a.m.   Olvi plc: Notification of Managers' Transactions (Rissanen)   Person subject to the notification requirement Name: Rissanen Marjatta Position: Other senior manager Issuer Name: Olvi plc LEI: 7437003NX7WWVRT6AJ55 Initial notification Reference number: 115337/4/4 Transaction details Transaction date: 1.7.2025 Venue: Outside a trading venue Nature of transaction: Receipt of a share-based incentive Instrument: Share ISIN: FI0009900401 Volume: 480  Unit price: 0 EUR Aggregated transactions Volume: 480...
04.07.25 - 07:01
Olvi plc: Notification of Managers′ Transactions (Liukkonen) (Cision)
 
Olvi plc   Stock exchange release 4 July 2025 at 8:00 a.m.   Olvi plc: Notification of Managers' Transactions (Liukkonen)   Person subject to the notification requirement Name: Liukkonen Tiina-Liisa Position: Chief Finance and Information Officer Issuer Name: Olvi plc LEI: 7437003NX7WWVRT6AJ55 Initial notification Reference number: 115327/4/4 Transaction details Transaction date: 1.7.2025 Venue: Outside a trading venue Nature of transaction: Receipt of a share-based incentive Instrument: Share ISIN: FI0009900401 Volume: 480 Unit price: 0 EUR Aggregated...
03.07.25 - 11:18
Olvi plc: Transfer of Treasury Shares Under a Performance Share Plan (Cision)
 
Olvi plc   Stock Exchange Release 3 July 2025 at 12.15 p.m.   Olvi plc: Transfer of Treasury Shares Under a Performance Share Plan Olvi plc has transferred a total of 4.196 Olvi plc Series A shares held as treasury shares to the company's key employees under a Performance Share Plan 2022-2024. In the plan, the target group was given an opportunity to earn Olvi plc series A shares based on performance. Information on the Performance Share Plan was provided in stock exchange release on 27 May 2022. Additionally, Olvi plc transferred 100 of Olvi plc Series A shares, whose...
22.05.25 - 15:36
Olvi plc: Transfer of Treasury Shares Under a Performance Share Plan (Cision)
 
Olvi plc   Stock Exchange Release 22 May 2025 at 4:30 p.m. Olvi plc: Transfer of Treasury Shares Under a Performance Share Plan Olvi plc has decided to transfer a total of 4.196 Olvi plc Series A shares held as treasury shares to the company's key employees under a Performance Share Plan 2022-2024. In the plan, the target group was given an opportunity to earn Olvi plc series A shares based on performance. Information on the Performance Share Plan was provided in stock exchange release on 27 May 2022. The transfer of shares through a directed share issue without payment is based...
23.04.25 - 08:07
Olvi Group′s interim report January–March 2025: profitability improved year-on-year, no turnaround yet in consumer demand (Cision)
 
Olvi plc                  Interim report 23 April 2025 at 9 am Olvi Group's interim report January–March 2025: profitability improved year-on-year, no turnaround yet in consumer demand January–March 2025 · Sales volume decreased by 2.9% to 199.2 (205.1) million litres. · Net sales increased by 1.9% and were EUR 132.8 (130.4) million. · Profitability improved: the adjusted operating result increased by 10.9% to EUR 12.4 (11.2) million. · The equity ratio was 61.8% (55.1%).   Near-term outlook for 2025 (unchanged)   Olvi Group's adjusted operating result for...
16.04.25 - 13:36
Resolutions of Olvi plc′s constitutive meeting of the Board of Directors (Cision)
 
Olvi plc   Stock exchange Release 16 April 2025 at 2:35 p.m.   Resolutions of Olvi plc's constitutive meeting of the Board of Directors In its constitutive meeting on 16 April 2025, held after the Annual General Meeting 2025, the Board of Directors of Olvi plc elected Nora Hortling as the Chair of the Board and Lasse Heinonen as the Vice Chair of the Board. The members of the Audit Committee are Lasse Heinonen (Chair), Tarmo Noop and Juho Nummela. The members of People and Sustainability Committee are Nora Hortling (Chair), Pekka Tiainen and Anette Vaini-Antila.   More...
16.04.25 - 12:24
Resolutions of Olvi plc′s Annual General Meeting 2025 (Cision)
 
Olvi plc   Stock Exchange Release 16 April 2025 at 13:20 p.m.   Resolutions of Olvi plc's Annual General Meeting 2025 Olvi plc's Annual General Meeting of 16 April 2025 adopted the financial statements and discharged the members of the Board of Directors and Chief Executive Officer from liability for the accounting period that ended on 31 December 2024. The General Meeting adopted the Remuneration Report 2024. In addition, the General Meeting made the following decisions: Dividend In accordance with the proposal of the Board of Directors, the General Meeting decided that a...
15.04.25 - 23:45
XFRA: DIVIDEND/INTEREST INFORMATION - 17.04.2025 - FI0009900401 (XETRA)
 
Das Instrument OVI FI0009900401 OLVI OY A EO 1 EQUITY wird cum Dividende/Zinsen gehandelt am 16.04.2025 und ex Dividende/Zinsen am 17.04.2025 The instrument OVI FI0009900401 OLVI OY A EO 1 EQUITY has its pre-dividend/interest day on 16.04.2025 and its ex-dividend/interest day on 17.04.2025...
28.03.25 - 21:12
Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire EN)
 
– Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer –...
25.03.25 - 13:33
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer (GlobeNewswire EN)
 
–  Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced a reduction in all target lesions, with one participant achieving a tumor reduction of approximately 79%....
25.03.25 - 13:33
Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease (GlobeNewswire EN)
 
- U.S. Food and Drug Administration states that data from the ongoing OnPrime/GOG-3076 Phase 3 registrational trial could potentially support traditional approval -...
21.03.25 - 08:06
NOTICE TO THE ANNUAL GENERAL MEETING (Cision)
 
Olvi plc  Notice of Annual General Meeting 21 March 2025 at 9.00 a.m.     NOTICE TO THE ANNUAL GENERAL MEETING   The shareholders of Olvi plc are hereby invited to the Annual General Meeting that will be held on Wednesday, 16 April 2025, at 11:00 am in the Olvi Beer Hall at Luuniemenkatu 4, Iisalmi, Finland. The reception of shareholders registered for the meeting and the distribution of voting slips will commence in the meeting venue at 10:00 am. Shareholders can also exercise their voting rights by voting in advance. Instructions for advance voting are presented in part C of...
21.03.25 - 08:06
Olvi plc′s Annual Report 2024 published (Cision)
 
Olvi plc   Annual Financial Report 21 March 2025 at 9:00 a.m.   Olvi plc's Annual Report 2024 published Olvi plc's Annual Report for 2024 has been published. The Annual Report includes the Financial Statements, the Board of Directors' Report, which includes the Sustainability Statement, as well as the Auditors' Report and the Assurance report on the Sustainability Statement. The Corporate Governance Statement and the Remuneration Report 2024 are attached to the Annual Report. The Financial Statements is published in accordance with the European Single Electronic Format (ESEF)...
20.03.25 - 16:01
Olvi plc: Notification of Managers′ Transactions (Lundell) (Cision)
 
Olvi plc   Stock exchange release 20 March 2025 at 5:00 p.m.   Olvi plc: Notification of Managers' Transactions (Lundell) Person subject to the notification requirement Name: Lundell Patrik Position: CEO Issuer Name: Olvi plc LEI: 7437003NX7WWVRT6AJ55 Initial notification Reference number: 100929/5/4 Transaction details Transaction date: 18.3.2025 Venue: Outside a trading venue Nature of transaction: Receipt of a share-based incentive Instrument: Share ISIN: FI0009900401 Volume: 500  Unit price: 0 EUR Aggregated transactions Volume: 500 Average price: 0 EUR...
19.12.24 - 14:00
The Board of Directors of Olvi plc has decided on new performance periods for long-term share-based incentive plans (Cision)
 
Olvi plc   Stock exchange release 19 December 2024 at 3:00 p.m. Other information disclosed according to the rules of the Exchange   The Board of Directors of Olvi plc has decided on new performance periods for long-term share-based incentive plans At its meeting on 19 December 2024, the Board of Directors of Olvi plc decided on a new performance period of the Performance Share Plan (PSP) for 2025–2027 and of the Restricted Share Plan (RS) for 2025–2026 and on the plans' participants, share amount and share allocation. Olvi has announced the establishment of these plans...
18.11.24 - 09:19
Olvi plc′s Financial Reports in 2025 (Cision)
 
Olvi plc                Stock Exchange Release 18 November 2024 at 10.15 am Olvi plc's Financial Reports in 2025 Olvi plc will issue a bulletin on the 2025 financial statements on 11 February 2025. The Annual Report will be released on 21 March 2025. The Annual Report will include the Board of Directors' Report, the Group's, and the parent company's Financial Statements, as well as the Auditors' Report regarding the accounting period 1 January to 31 December 2024. The Annual Report includes Corporate Governance Statement and Remuneration Report for the fiscal year 2024. Olvi plc...
29.10.24 - 20:06
Genelux started at buy by Guggenheim ahead of Olvi-vec data (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.24 - 22:03
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer (GlobeNewswire EN)
 
– VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician's choice of immune checkpoint inhibitor compared to docetaxel in recurrent non-small cell lung cancer –...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Männer sind wie Luft, zwar versaut, aber unentbehrlich. - Michelle Pfeiffer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!